TAILIN BIOTECH(SZ:300813)2025-09-09 09:00Company Overview - Zhejiang Tailin Biological Technology Co., Ltd. was listed on the Shenzhen Stock Exchange's Growth Enterprise Market in January 2020, focusing on life science system solutions [2] - The company provides a one-stop series of complete equipment, precision instruments, and supporting consumables for life science research and industry [2] Research and Development Focus - Current R&D investments are concentrated in three main areas: 1. Microbial detection and control, specifically in industrial microbiology and water ecological monitoring [4] 2. Quality control in pharmaceutical health products, innovative drug production assurance, and safety of major disease treatment drugs [4] 3. Advanced technologies such as cavity ring-down spectroscopy and particle laser imaging [4] Semiconductor Industry Engagement - The company’s subsidiary hosted a seminar on TOC analysis technology for semiconductor water, showcasing breakthroughs in this area [4] - Products like the GM200e and DC200e TOC analyzers are being utilized in ultra-pure water and wastewater applications within the semiconductor industry, with the DC200e achieving a detection limit of 0.030 ppb and an accuracy of ±0.1 ppb [4] - The semiconductor sector remains a small portion of the company's overall business, but it is a key development direction for the year [4] Financial Performance and Market Expansion - International business grew significantly, with a 36% increase in volume compared to the same period last year, accounting for 17% of total business [6] - The company’s overseas revenue for the first half of 2025 reached 22 million, with a growth rate of 43% [6] - Major growth markets include Asia, Africa, and the Americas, focusing on integrity testing instruments, organic analysis series, and microbial detection products [6] Cost and Expenses - Share-based payment expenses for the first half of 2025 were 107.7 thousand yuan (unaudited), with an estimated 323.11 thousand yuan for the second half [6]